
Accuray (ARAY) Stock Forecast & Price Target
Accuray (ARAY) Analyst Ratings
Bulls say
Accuray is facing a challenging environment with geopolitical uncertainty impacting revenue growth and profitability. Despite efforts to cut costs and improve operational efficiencies, the company has missed its financial targets and removed its financial guidance due to uncertainties in the Middle East. With multiples contracting in the MedTech sector and declining revenue, it is unlikely that investors will have an appetite for ARAY, leading to a downgrade from Buy to Neutral and removal of price target.
Bears say
Accuray is facing multiple challenges including geopolitical uncertainty, weak commercial execution and profitability, and potential risks such as tariffs and supply chain disruptions. These factors, along with the lack of progress in operating improvements and a lengthy timeline for potential improvements, contribute to our negative outlook on the stock. Additionally, the company's financials show a decline in revenue and orders, and a missed earnings estimate in the most recent quarter.
This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.
Accuray (ARAY) Analyst Forecast & Price Prediction
Start investing in Accuray (ARAY)
Order type
Buy in
Order amount
Est. shares
0 shares